Phreesia Price to Sales Ratio 2019-2026 | PHR
Historical PS ratio values for Phreesia (PHR) over the last 10 years. The current P/S ratio for Phreesia as of June 15, 2026 is .
| Phreesia P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-06-15 | 9.15 | 1.14 | |
| 2026-04-30 | 9.21 | $8.03 | 1.15 |
| 2026-01-31 | 13.43 | $7.89 | 1.70 |
| 2025-10-31 | 22.64 | $7.73 | 2.93 |
| 2025-07-31 | 26.96 | $7.62 | 3.54 |
| 2025-04-30 | 24.96 | $7.49 | 3.33 |
| 2025-01-31 | 28.46 | $7.31 | 3.89 |
| 2024-10-31 | 18.29 | $7.15 | 2.56 |
| 2024-07-31 | 24.95 | $6.96 | 3.58 |
| 2024-04-30 | 20.74 | $6.78 | 3.06 |
| 2024-01-31 | 25.48 | $6.57 | 3.88 |
| 2023-10-31 | 13.66 | $6.29 | 2.17 |
| 2023-07-31 | 31.72 | $6.02 | 5.27 |
| 2023-04-30 | 31.64 | $5.72 | 5.53 |
| 2023-01-31 | 37.49 | $5.37 | 6.99 |
| 2022-10-31 | 27.32 | $5.07 | 5.39 |
| 2022-07-31 | 23.49 | $4.78 | 4.92 |
| 2022-04-30 | 22.88 | $4.49 | 5.10 |
| 2022-01-31 | 31.19 | $4.33 | 7.20 |
| 2021-10-31 | 70.54 | $4.23 | 16.69 |
| 2021-07-31 | 68.35 | $4.13 | 16.56 |
| 2021-04-30 | 51.75 | $4.05 | 12.78 |
| 2021-01-31 | 65.29 | $3.88 | 16.83 |
| 2020-10-31 | 36.97 | $4.44 | 8.33 |
| 2020-07-31 | 30.06 | $4.36 | 6.90 |
| 2020-04-30 | 25.39 | $7.97 | 3.19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.490B | $0.481B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |